Belize still reports a 73% in the pregnant women living with hiv antiretroviral therapy coverage for pmtct, unchanged since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Belize
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Belize
PMTCT antiretroviral therapy coverage
More indicators for Belize
Male unintentional poisoning
0.5
0.0
(2019)
Female wasting in children
1.4%
-2%
(2015)
Female prevalence of HIV
0.5%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar109
+intl dollar17
(2021)
Birth registration
95.7%
+0.5%
(2015)
Contraceptive modern method prevalence
48.5%
-3.5%
(2016)
Belize PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 73% | 0% |
| 2021 | 73% | +1% |
| 2020 | 72% | +4% |
| 2019 | 68% | -6% |
| 2018 | 74% | +7% |
| 2017 | 67% | +9% |
| 2016 | 58% | -21% |
| 2015 | 79% | 0% |
| 2014 | 79% | +9% |
| 2013 | 70% | -26% |
| 2012 | 96% | -4% |
| 2011 | 100% | +5% |
| 2010 | 95% | -5% |
| 2009 | 100% | +34% |
| 2008 | 66% | -4% |
| 2007 | 70% | -12% |
| 2006 | 82% | +30% |
| 2005 | 52% | -5% |
| 2004 | 57% | -13% |
| 2003 | 70% | +10% |
| 2002 | 60% | -11% |
| 2001 | 71% | +71% |
| 2000 | 0% |